FDA Drug Application (021841) for LAMIVUDINE/ZIDOVUDINE TABLETS CO-PACKAGED WITH NEVIRAPINE TABLETS by PHARMACARE LTD

Back to FDA Applications sponsored by PHARMACARE LTD

Application Number021841
Product Number001
FormTABLET; ORAL
Dosage150MG; 300MG; 200MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE/ZIDOVUDINE TABLETS CO-PACKAGED WITH NEVIRAPINE TABLETS
Active IngredientLAMIVUDINE; ZIDOVUDINE; NEVIRAPINE



Back to FDA Applications sponsored by PHARMACARE LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.